Shot in the arm for Africa vaccine output as Aspen gets R10bn

South Africa’s biggest pharmaceutical manufacturer, Aspen Pharmacare, is to receive a €600m (R10.1bn) long-term debt financing package from a consortium of development financiers led by the World Bank’s International Finance Corporation (IFC) to support the development of vaccine manufacturing capacity in Africa...

This article is reserved for DispatchLIVE subscribers.

Get access to ALL DispatchLIVE content from only R45.00 per month.

Already subscribed? Simply sign in below.

Already registered on HeraldLIVE, BusinessLIVE, TimesLIVE or SowetanLIVE? Sign in with the same details.



Questions or problems? Email helpdesk@dispatchlive.co.za or call 0860 52 52 00.